下调和上调
染色质免疫沉淀
核糖核酸
分子生物学
生物
细胞毒性T细胞
信使核糖核酸
CD8型
T细胞
细胞生物学
基因表达
癌症研究
基因
免疫系统
发起人
免疫学
生物化学
体外
作者
Shaoyan Cheng,Feng Li,Haiming Qin,Yu P,Qitai Zhao,Qun Gao,Mengjia Song,Jiao Qu,Jiqi Shan,Kai Zhang,Zhen Zhang,Jingyao Lian,Shasha Liu,Liping Wang,Yi Zhang
出处
期刊:Journal of Immunology
[The American Association of Immunologists]
日期:2022-03-15
卷期号:208 (6): 1483-1492
被引量:7
标识
DOI:10.4049/jimmunol.2100602
摘要
Therapies targeting programmed cell death protein 1 (PD-1) have gained great success in patients with multiple types of cancer. The regulatory mechanisms underlying PD-1 expression have been extensively explored. However, the impact of long noncoding RNAs on PD-1 expression remains elusive. In this study, we identified the Notch1/lncNDEPD1 axis, which plays a critical role in PD-1 expression in human CD8+ T cells. RNA sequencing and quantitative reverse transcription PCR data showed that lncNDEPD1 was upregulated in activated T cells, especially in PD-1high subsets. Fluorescence in situ hybridization demonstrated that lncNDEPD1 was localized in the cytoplasm. A mechanistic study showed that lncNDEPD1 could bind with miR-3619-5p and PDCD1 mRNA to prevent PDCD1 mRNA degradation and then upregulate PD-1 expression. A chromatin immunoprecipitation assay showed that Notch1 directly binds to the promoter of lncNDEPD1 instead of PDCD1 Furthermore, chimeric Ag receptor T cells expressing lncNDEPD1-specific short hairpin RNAs were generated. Chimeric Ag receptor T cells with decreased lncNDEPD1 expression showed enhanced tumoricidal effects when PD-L1 was present. Our work uncovered a new regulatory mechanism of PD-1 expression and thus provided a potential target to decrease PD-1 without affecting T cell function.
科研通智能强力驱动
Strongly Powered by AbleSci AI